Hologic
This article was originally published in The Gray Sheet
Executive Summary
Firm names John Cumming president/CEO Aug. 1. Cumming joined the firm in August 2000 as senior-VP and president of Hologic's Lorad subsidiary. Jay Stein, who served as interim CEO following the death of David Ellenbogen June 21, retains the post of chief technology officer and chairman (1"The Gray Sheet" July 2, 2001, In Brief). Steve Nakashige, president/chief operating officer, has resigned "to pursue other business opportunities," Hologic says
You may also be interested in...
Hologic's David Ellenbogen
Jay Stein, Hologic executive VP and chief technology officer, is appointed chairman and interim CEO following the death of Chairman, CEO and co-founder Ellenbogen June 21 due to heart failure
Chinese Firms Up Their Game In Novel Flu Antiviral Development
Joincare Pharmaceutical and partner TaiGen Biotechnology tout preliminary Phase III results in uncomplicated acute influenza for TG-1000, a homegrown follower of Shionogi/Roche’s oral antiviral Xofluza. Novel antivirals for flu were hotly pursued by Chinese developers throughout 2023.
Quotable: Words Of Wisdom From Our Recent APAC Coverage
Scrip's APAC team selects notable quotes from recent interviews, conferences and other coverage to highlight the views of senior executives and officials on the major topics facing the biopharma sector in the region.